Kidney transplant outcome of expanded criteria donors after circulatory death
Related Experiment Video
Updated: Nov 1, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Paloma Barreda Monteoliva1, Dolores Redondo-Pachón2, Eduardo Miñambres García3
1Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla/IDIVAL, Universidad de Cantabria, Santander, España.
Insights
Kidney transplants are increasing using donors after cardiac death (DCD) and expanded criteria (ECD). While these grafts may have more delayed function, they offer comparable long-term survival, shortening transplant waiting lists.
Area of Science:
- Nephrology
- Transplantation Surgery
- Organ Donation
Background:
- Rising kidney transplant waiting lists necessitate expanding donor pools.
- Donors after cardiac death (DCD) and expanded criteria donors (ECD) are increasingly utilized.
- Controlled DCD (cDCD) grafts, despite higher delayed graft function (DGF), show comparable long-term outcomes to brain-dead donors.
Purpose of the Study:
- To evaluate the outcomes of kidney transplants using cDCD/ECD grafts.
- To compare the efficacy of cDCD/ECD grafts against other donor types.
- To assess factors influencing mortality and graft survival in cDCD/ECD recipients.
Main Methods:
- Analysis of kidney transplant data involving cDCD/ECD grafts.
- Comparison of graft function, survival rates, and recipient mortality.
- Evaluation of recipient age and surgical factors (cold ischemia time).
Main Results:
- cDCD/ECD grafts are associated with increased DGF but similar long-term graft survival compared to brain-dead expanded criteria donors.
- Recipients of cDCD/ECD grafts exhibit poorer kidney function than those receiving cDCD/standard or brain-dead/ECD grafts.
- Recipient age is a primary factor in mortality for cDCD/ECD recipients; survival benefits are noted for cDCD/≥60 grafts.
Conclusions:
- cDCD/ECD grafts are a viable option to shorten kidney transplant waiting lists.
- Optimizing surgical techniques and minimizing cold ischemia are crucial for cDCD/ECD graft success.
- Careful patient selection, considering recipient age, is essential for maximizing survival benefits.
Abstract:
The increase in the number of patients on the kidney transplant waiting list has led to an attempt to increase the number of potential donors by incorporating candidates that previously would not have been considered optimal, including donors after cardiac death (DCD) and those with "expanded" criteria (ECD). Recipients of controlled DCD (cDCD) grafts suffer more delayed graft function (DGF), but have a long-term evolution comparable to those of brain-dead donors, which has allowed an increase in the number of cDCD transplants in different countries in recent years. In parallel, the use of cDCD with expanded criteria (cDCD/ECD) has increased in recent years in different countries, allowing the waiting list for kidney transplantation to be shortened. The use of these grafts, although associated with a higher frequency of DGF, offers similar or only slightly lower long-term graft survival than those of brain death donors with expanded criteria. Different studies have observed that cDCD/ECD graft recipients have worse kidney function than cDCD/standard and brain death/ECD. Mortality associated with cDCD/ECD graft transplantation mostly relates to the recipient age. Patients who receive a cDCD/≥60 graft have better survival than those who continue on the waiting list, although this fact has not been demonstrated in recipients of cDCD/>65 years. The use of this type of organ should be accompanied by the optimization of surgical times and the shortest possible cold ischemia.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

